Review





Similar Products

94
TargetMol interferon alpha 2 ifna2 protein human recombinant hfc
Interferon Alpha 2 Ifna2 Protein Human Recombinant Hfc, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Interferon+alpha+2%2FIFNA2+Protein%2C+Human%2C+Recombinant/pm42956743-882-78-85
Average 94 stars, based on 1 article reviews
interferon alpha 2 ifna2 protein human recombinant hfc - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
PBL Assay universal interferon alpha
Universal Interferon Alpha, supplied by PBL Assay, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Universal+Type+I+Interferon/bio_rxiv__64898__2026__11__04__763981-276-14-18
Average 97 stars, based on 1 article reviews
universal interferon alpha - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Cusabio human ifn β
A104R targets of KPNA proteins and inhibits type I <t>IFN</t> signaling . A HEK293T cells were cotransfected with an <t>IFN-β</t> promoter-driven firefly luciferase reporter, TK-Renilla control, the indicated stimulators (STING, TBK1, IKKε, IRF3, or IRF3-5D), and increasing amounts of Flag-A104R. For poly(dA:dT) stimulation, cells received both reporters, Flag-A104R, and poly(dA:dT). Firefly activity was normalized to Renilla activity at 24 h. For cGAS- and cGAMP-induced assays, 293-Dual hSTING-A162 cells expressing Flag-A104R were transfected with 3×Flag-cGAS or stimulated with 2′3′-cGAMP. Secreted IFN-β-dependent Lucia luciferase activity was measured after 12 h. White, black, and gray bars represent negative control, positive control, and increasing Flag-A104R doses, respectively. B Silver-stained GST-A104R pull-down products analyzed by mass spectrometry. The positions of GST-A104R, KPNA3 (UniProt O00505 ), and KPNA4 (UniProt O00629 ) are indicated. C HEK293T cells were cotransfected with Flag-KPNA1–6 or control vector and Strep-A104R. After 36 h, anti-Flag immunoprecipitates were immunoblotted with the indicated antibodies. Values show Strep-A104R intensity normalized to the corresponding Flag bait. D , E Flag-A104R-expressing or control 3D4/21 cells were subjected to anti-Flag immunoprecipitation and immunoblotting for KPNA3 ( D ) or KPNA4 ( E ). Values indicate KPNA3 or KPNA4 intensity normalized to immunoprecipitated Flag-A104R. F , G Confocal microscopy of PK-15 cells co-expressing Strep-A104R and Flag-KPNA3 ( F ) or Flag-KPNA4 ( G ). A104R, KPNA proteins, and nuclei are shown in red, green, and blue, respectively; yellow indicates colocalization. Scale bar indicates 20 μm. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment ( A ). Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001.
Human Ifn β, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Human+Interferon+%CE%B2%2CIFN-%CE%B2%2FIFNB+ELISA+Kit/pmc13744117-97-16-18
Average 94 stars, based on 1 article reviews
human ifn β - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology cxcl9
Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) <t>CXCL9.</t> (e) CXCL10.
Cxcl9, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Mouse+MI%CE%B3%2FCXCL9+(Monocyte+Interferon+Gamma+Inducing+Factor)+ELISA+Kit/bio_rxiv__64898__2026__11__04__764456-53-9-20
Average 94 stars, based on 1 article reviews
cxcl9 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology cxcl10
Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) <t>CXCL10.</t>
Cxcl10, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Mouse+IP-10%2FCXCL10+(Interferon+Gamma+Induced+Protein+10kDa)+ELISA+Kit/bio_rxiv__64898__2026__11__04__764456-53-12-20
Average 94 stars, based on 1 article reviews
cxcl10 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Elabscience Biotechnology serum levels
Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) <t>IFN-γ.</t> (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.
Serum Levels, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Mouse+IFN-%CE%B3+(Interferon+Gamma)+ELISA+Kit/bio_rxiv__64898__2026__11__04__764456-53-0-20
Average 96 stars, based on 1 article reviews
serum levels - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Boster Bio human ifn γ
(A) Schematics of NK cell activating receptors. B Gene (left) and protein (right) schematics of the chimeric receptors. C Membrane surface expression of chimeric receptors on NK92MI cell line determined by flow cytometry. D Mean fluorescence intensity (MFI) of CD69 expression on transduced NK92MI cells, determined by flow cytometry, after 24 hours coculture with CD19⁺ Nalm6 cells. ( E and F ) Cytokine productions of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 <t>hours.</t> <t>IFN-γ</t> ( E ) and TNF-α ( F ) were measured. G Degranulation marker CD107a of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. H Cytotoxicity of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1.Data are presented as mean with SD (n = 3; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).
Human Ifn γ, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Human+IFN+Gamma%2FIFNG%2FInterferon+Gamma+ELISA+Kit+PicoKine/bio_rxiv__64898__2026__11__02__763574-194-18-20
Average 93 stars, based on 1 article reviews
human ifn γ - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
PBL Assay universal type i ifn
(A) Validation of FLAG-Dicer immunoprecipitation (used for proteomics) in HEK293-L cells treated with siControl, siADAR1, or siADAR1 + ruxolitinib (n=3). Input and IP fractions analysed by immunoblot. EV, empty vector; siA, siADAR1; Rux, ruxolitinib. (B) Principal component analysis of proteomics samples from (A); biological replicates indicated by matching symbols. (C-D) Volcano plots showing changes in Dicer interactome 72h after siADAR1 treatment (n=3). Enriched Dicer interactors in siADAR1 treated samples are highlighted in purple. (C) Enriched Dicer interactors after siADAR1 treatment, versus siControl. (D) Enriched Dicer interactors in siADAR1 + ruxolitinib treatment, versus siControl. (E) Transcript levels of enriched Dicer interactors after siADAR1 treatment in (C) (n=3). Transcript levels shown as the fold change of the counts per million (CPM) after siADAR1 treatment from transcriptomics shown in of HEK293-L cells, 72h post-siRNA transfection. (F) GO-enrichment analysis of Dicer interactors 72h post-siRNA transfection. Color-coded by GO-term similarity; ribosome-related GO-terms are labelled green and translation-related GO-terms are labelled blue. (G) Volcano plot of Dicer interactome after 72h in siControl-treated HEK293-L cells (n=3). Interactors overlapping with the GO term Regulation of <t>type</t> <t>I</t> <t>IFN</t> response are named and highlighted red, or blue for those chosen for further study. Curved line in volcano plots indicates the significance boundary based on a hyperbolic threshold combining fold change and p-value criteria.
Universal Type I Ifn, supplied by PBL Assay, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Universal+Type+I+Interferon/bio_rxiv__64898__2026__10__29__761885-206-0-6
Average 97 stars, based on 1 article reviews
universal type i ifn - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
PBL Assay recombinant human ifn α2a
(A) Validation of FLAG-Dicer immunoprecipitation (used for proteomics) in HEK293-L cells treated with siControl, siADAR1, or siADAR1 + ruxolitinib (n=3). Input and IP fractions analysed by immunoblot. EV, empty vector; siA, siADAR1; Rux, ruxolitinib. (B) Principal component analysis of proteomics samples from (A); biological replicates indicated by matching symbols. (C-D) Volcano plots showing changes in Dicer interactome 72h after siADAR1 treatment (n=3). Enriched Dicer interactors in siADAR1 treated samples are highlighted in purple. (C) Enriched Dicer interactors after siADAR1 treatment, versus siControl. (D) Enriched Dicer interactors in siADAR1 + ruxolitinib treatment, versus siControl. (E) Transcript levels of enriched Dicer interactors after siADAR1 treatment in (C) (n=3). Transcript levels shown as the fold change of the counts per million (CPM) after siADAR1 treatment from transcriptomics shown in of HEK293-L cells, 72h post-siRNA transfection. (F) GO-enrichment analysis of Dicer interactors 72h post-siRNA transfection. Color-coded by GO-term similarity; ribosome-related GO-terms are labelled green and translation-related GO-terms are labelled blue. (G) Volcano plot of Dicer interactome after 72h in siControl-treated HEK293-L cells (n=3). Interactors overlapping with the GO term Regulation of <t>type</t> <t>I</t> <t>IFN</t> response are named and highlighted red, or blue for those chosen for further study. Curved line in volcano plots indicates the significance boundary based on a hyperbolic threshold combining fold change and p-value criteria.
Recombinant Human Ifn α2a, supplied by PBL Assay, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/Human+Interferon+Alpha+A+-+Alpha+2a/pm42971437-63-0-6
Average 96 stars, based on 1 article reviews
recombinant human ifn α2a - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
PBL Assay verikine hs human interferon alfa tcm elisa
(A) Validation of FLAG-Dicer immunoprecipitation (used for proteomics) in HEK293-L cells treated with siControl, siADAR1, or siADAR1 + ruxolitinib (n=3). Input and IP fractions analysed by immunoblot. EV, empty vector; siA, siADAR1; Rux, ruxolitinib. (B) Principal component analysis of proteomics samples from (A); biological replicates indicated by matching symbols. (C-D) Volcano plots showing changes in Dicer interactome 72h after siADAR1 treatment (n=3). Enriched Dicer interactors in siADAR1 treated samples are highlighted in purple. (C) Enriched Dicer interactors after siADAR1 treatment, versus siControl. (D) Enriched Dicer interactors in siADAR1 + ruxolitinib treatment, versus siControl. (E) Transcript levels of enriched Dicer interactors after siADAR1 treatment in (C) (n=3). Transcript levels shown as the fold change of the counts per million (CPM) after siADAR1 treatment from transcriptomics shown in of HEK293-L cells, 72h post-siRNA transfection. (F) GO-enrichment analysis of Dicer interactors 72h post-siRNA transfection. Color-coded by GO-term similarity; ribosome-related GO-terms are labelled green and translation-related GO-terms are labelled blue. (G) Volcano plot of Dicer interactome after 72h in siControl-treated HEK293-L cells (n=3). Interactors overlapping with the GO term Regulation of <t>type</t> <t>I</t> <t>IFN</t> response are named and highlighted red, or blue for those chosen for further study. Curved line in volcano plots indicates the significance boundary based on a hyperbolic threshold combining fold change and p-value criteria.
Verikine Hs Human Interferon Alfa Tcm Elisa, supplied by PBL Assay, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferone/VeriKine-HS+Human+IFN-Alpha+All-Subtype+TCM+ELISA+Kit/10__3390_slash_microorganisms14112496-113-7-14
Average 94 stars, based on 1 article reviews
verikine hs human interferon alfa tcm elisa - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


A104R targets of KPNA proteins and inhibits type I IFN signaling . A HEK293T cells were cotransfected with an IFN-β promoter-driven firefly luciferase reporter, TK-Renilla control, the indicated stimulators (STING, TBK1, IKKε, IRF3, or IRF3-5D), and increasing amounts of Flag-A104R. For poly(dA:dT) stimulation, cells received both reporters, Flag-A104R, and poly(dA:dT). Firefly activity was normalized to Renilla activity at 24 h. For cGAS- and cGAMP-induced assays, 293-Dual hSTING-A162 cells expressing Flag-A104R were transfected with 3×Flag-cGAS or stimulated with 2′3′-cGAMP. Secreted IFN-β-dependent Lucia luciferase activity was measured after 12 h. White, black, and gray bars represent negative control, positive control, and increasing Flag-A104R doses, respectively. B Silver-stained GST-A104R pull-down products analyzed by mass spectrometry. The positions of GST-A104R, KPNA3 (UniProt O00505 ), and KPNA4 (UniProt O00629 ) are indicated. C HEK293T cells were cotransfected with Flag-KPNA1–6 or control vector and Strep-A104R. After 36 h, anti-Flag immunoprecipitates were immunoblotted with the indicated antibodies. Values show Strep-A104R intensity normalized to the corresponding Flag bait. D , E Flag-A104R-expressing or control 3D4/21 cells were subjected to anti-Flag immunoprecipitation and immunoblotting for KPNA3 ( D ) or KPNA4 ( E ). Values indicate KPNA3 or KPNA4 intensity normalized to immunoprecipitated Flag-A104R. F , G Confocal microscopy of PK-15 cells co-expressing Strep-A104R and Flag-KPNA3 ( F ) or Flag-KPNA4 ( G ). A104R, KPNA proteins, and nuclei are shown in red, green, and blue, respectively; yellow indicates colocalization. Scale bar indicates 20 μm. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment ( A ). Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R targets of KPNA proteins and inhibits type I IFN signaling . A HEK293T cells were cotransfected with an IFN-β promoter-driven firefly luciferase reporter, TK-Renilla control, the indicated stimulators (STING, TBK1, IKKε, IRF3, or IRF3-5D), and increasing amounts of Flag-A104R. For poly(dA:dT) stimulation, cells received both reporters, Flag-A104R, and poly(dA:dT). Firefly activity was normalized to Renilla activity at 24 h. For cGAS- and cGAMP-induced assays, 293-Dual hSTING-A162 cells expressing Flag-A104R were transfected with 3×Flag-cGAS or stimulated with 2′3′-cGAMP. Secreted IFN-β-dependent Lucia luciferase activity was measured after 12 h. White, black, and gray bars represent negative control, positive control, and increasing Flag-A104R doses, respectively. B Silver-stained GST-A104R pull-down products analyzed by mass spectrometry. The positions of GST-A104R, KPNA3 (UniProt O00505 ), and KPNA4 (UniProt O00629 ) are indicated. C HEK293T cells were cotransfected with Flag-KPNA1–6 or control vector and Strep-A104R. After 36 h, anti-Flag immunoprecipitates were immunoblotted with the indicated antibodies. Values show Strep-A104R intensity normalized to the corresponding Flag bait. D , E Flag-A104R-expressing or control 3D4/21 cells were subjected to anti-Flag immunoprecipitation and immunoblotting for KPNA3 ( D ) or KPNA4 ( E ). Values indicate KPNA3 or KPNA4 intensity normalized to immunoprecipitated Flag-A104R. F , G Confocal microscopy of PK-15 cells co-expressing Strep-A104R and Flag-KPNA3 ( F ) or Flag-KPNA4 ( G ). A104R, KPNA proteins, and nuclei are shown in red, green, and blue, respectively; yellow indicates colocalization. Scale bar indicates 20 μm. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment ( A ). Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Luciferase, Control, Activity Assay, Expressing, Transfection, Negative Control, Positive Control, Staining, Pull Down Assay, Mass Spectrometry, Plasmid Preparation, Immunoprecipitation, Western Blot, Confocal, Microscopy, GST Pulldown Assay

A104R negatively regulates antiviral immune responses in stable 3D4/21 cells. A–C Stable 3D4/21 cells expressing Flag-A104R or the control vector were infected with ADV-GFP, HSV-GFP, or VACV-GFP, respectively, at a multiplicity of infection (MOI) of 1.0. At 12 and 24 h post-infection (hpi), fluorescence intensity levels were quantified, and GFP fluorescence images were captured at 24 hpi. Standard plaque assays were performed in A549 or Vero cells for viral titer determination. D–F Porcine IFN-β and IL-6 concentrations in culture supernatants collected at 12 and 24 hpi were measured by ELISA. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. Scale bar indicates 50 μm.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R negatively regulates antiviral immune responses in stable 3D4/21 cells. A–C Stable 3D4/21 cells expressing Flag-A104R or the control vector were infected with ADV-GFP, HSV-GFP, or VACV-GFP, respectively, at a multiplicity of infection (MOI) of 1.0. At 12 and 24 h post-infection (hpi), fluorescence intensity levels were quantified, and GFP fluorescence images were captured at 24 hpi. Standard plaque assays were performed in A549 or Vero cells for viral titer determination. D–F Porcine IFN-β and IL-6 concentrations in culture supernatants collected at 12 and 24 hpi were measured by ELISA. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. Scale bar indicates 50 μm.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Expressing, Control, Plasmid Preparation, Infection, Fluorescence, Titer Analysis, Enzyme-linked Immunosorbent Assay

A104R and phosphorylated STAT1 bind to overlapping regions of KPNA6. A Flag-A104R-expressing stable 3D4/21 cells were subjected to anti-Flag immunoprecipitation and immunoblotting. KPNA6 intensity was normalized to immunoprecipitated Flag-A104R. B HEK293T cells co-expressing Flag-STAT1 and GST-KPNA6 were treated with IFN-β (1000 U/mL) for 1 h at 36 hpt. GST pull-down products were analyzed by immunoblotting, and phosphorylated STAT1 (pSTAT1) intensity was normalized to pulled-down GST-KPNA6. C HEK293T cells expressing Flag-KPNA1–6 were treated with IFN-β (1000 U/mL) for 1 h and subjected to anti-Flag immunoprecipitation. pSTAT1 intensity was normalized to the corresponding immunoprecipitated Flag-KPNA bait. D Schematic representation of GST-tagged KPNA6 constructs. Predicted molecular weights were 34, 42, 55, and 76 kDa for residues 1–80, 1–150, 1–290, and 1–460, respectively; 55 kDa for residues 270–535; and 85 kDa for full-length KPNA6 (535 aa). E HEK293T cells co-expressing GST-KPNA6 constructs and Flag-A104R were subjected to GST pull-down and immunoblotting. Flag-A104R intensity was normalized to the corresponding GST bait. F HEK293T cells co-expressing GST-KPNA6, Flag-STAT1, and Strep-A104R were harvested at 36 h for GST pull-down and immunoblotting. pSTAT1 and Strep-A104R intensities were normalized to GST-KPNA6. G Flag-A104R-expressing 3D4/21 cells were treated with IFN-β (1000 U/mL) for 1 h and subjected to KPNA6 immunoprecipitation and immunoblotting. pSTAT1 and Flag-A104R intensities were normalized to immunoprecipitated KPNA6.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R and phosphorylated STAT1 bind to overlapping regions of KPNA6. A Flag-A104R-expressing stable 3D4/21 cells were subjected to anti-Flag immunoprecipitation and immunoblotting. KPNA6 intensity was normalized to immunoprecipitated Flag-A104R. B HEK293T cells co-expressing Flag-STAT1 and GST-KPNA6 were treated with IFN-β (1000 U/mL) for 1 h at 36 hpt. GST pull-down products were analyzed by immunoblotting, and phosphorylated STAT1 (pSTAT1) intensity was normalized to pulled-down GST-KPNA6. C HEK293T cells expressing Flag-KPNA1–6 were treated with IFN-β (1000 U/mL) for 1 h and subjected to anti-Flag immunoprecipitation. pSTAT1 intensity was normalized to the corresponding immunoprecipitated Flag-KPNA bait. D Schematic representation of GST-tagged KPNA6 constructs. Predicted molecular weights were 34, 42, 55, and 76 kDa for residues 1–80, 1–150, 1–290, and 1–460, respectively; 55 kDa for residues 270–535; and 85 kDa for full-length KPNA6 (535 aa). E HEK293T cells co-expressing GST-KPNA6 constructs and Flag-A104R were subjected to GST pull-down and immunoblotting. Flag-A104R intensity was normalized to the corresponding GST bait. F HEK293T cells co-expressing GST-KPNA6, Flag-STAT1, and Strep-A104R were harvested at 36 h for GST pull-down and immunoblotting. pSTAT1 and Strep-A104R intensities were normalized to GST-KPNA6. G Flag-A104R-expressing 3D4/21 cells were treated with IFN-β (1000 U/mL) for 1 h and subjected to KPNA6 immunoprecipitation and immunoblotting. pSTAT1 and Flag-A104R intensities were normalized to immunoprecipitated KPNA6.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Expressing, Immunoprecipitation, Western Blot, GST Pulldown Assay, Construct

A104R binding to KPNA6 does not alter STAT1 phosphorylation but reduces phosphorylated STAT1 nuclear transport. A HEK293T cells were cotransfected with Flag-tagged STAT1 and increasing amounts of Strep-tagged A104R. At 36 hpt, cells were treated with IFN-β (1000 U/mL) for 1 h, and cell lysates were analyzed by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B Cells were treated with IFN-β (1000 U/mL) for 2 h, lysed, and subjected to immunoprecipitation with IRF9 antibody to assess endogenous ISGF3 complex formation. The numerical values below the anti-STAT1, -STAT2, and -Flag panels in the IP: IRF9 represent the relative intensity of the STAT1, STAT2, and Flag-A104R signals, normalized to the IRF9 bait in the same IP: IRF9. C Stable 3D4/21 cells expressing Flag-A104R were treated with IFN-β at the indicated timepoints. Cytoplasmic and nuclear fractions were prepared using a Nuclear and Cytoplasmic Protein Extraction Kit and analyzed separately by immunoblotting. The numerical values below the panels in the nuclear and cytoplasmic fractions represent the relative intensity normalized to the internal controls of Lamin B1 and α-Tubulin, respectively. D Control- and Flag-A104R-expressing PK-15 cells were treated with IFN-β (1000 U/mL) at the indicated timepoints. Flag-A104R was detected using an anti-Flag antibody and a Cy3-conjugated secondary antibody. STAT1 and A104R are shown in green and red, respectively. Scale bar indicates 20 μm.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R binding to KPNA6 does not alter STAT1 phosphorylation but reduces phosphorylated STAT1 nuclear transport. A HEK293T cells were cotransfected with Flag-tagged STAT1 and increasing amounts of Strep-tagged A104R. At 36 hpt, cells were treated with IFN-β (1000 U/mL) for 1 h, and cell lysates were analyzed by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B Cells were treated with IFN-β (1000 U/mL) for 2 h, lysed, and subjected to immunoprecipitation with IRF9 antibody to assess endogenous ISGF3 complex formation. The numerical values below the anti-STAT1, -STAT2, and -Flag panels in the IP: IRF9 represent the relative intensity of the STAT1, STAT2, and Flag-A104R signals, normalized to the IRF9 bait in the same IP: IRF9. C Stable 3D4/21 cells expressing Flag-A104R were treated with IFN-β at the indicated timepoints. Cytoplasmic and nuclear fractions were prepared using a Nuclear and Cytoplasmic Protein Extraction Kit and analyzed separately by immunoblotting. The numerical values below the panels in the nuclear and cytoplasmic fractions represent the relative intensity normalized to the internal controls of Lamin B1 and α-Tubulin, respectively. D Control- and Flag-A104R-expressing PK-15 cells were treated with IFN-β (1000 U/mL) at the indicated timepoints. Flag-A104R was detected using an anti-Flag antibody and a Cy3-conjugated secondary antibody. STAT1 and A104R are shown in green and red, respectively. Scale bar indicates 20 μm.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Binding Assay, Phospho-proteomics, Western Blot, Control, Immunoprecipitation, Expressing, Protein Extraction

A104R inhibits IFN-β-induced JAK/STAT signaling. A Cells transfected with the vector control or A104R were treated with IFN-β for 0, 0.5, 1, 2, or 4 h. Phosphorylation of JAK1, TYK2, STAT1, and STAT2 was analyzed by immunoblotting. A104R expression was confirmed by detection of Flag-tagged A104R The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B The 3D4/21 cells were transfected with Flag-tagged A104R or the control vector and treated with IFN-β for 2 h. At the indicated timepoints, total RNA was extracted and the mRNA levels of the indicated genes were measured by RT-qPCR. C The 3D4/21 cells expressing the control vector or A104R were infected with ADV-GFP in the absence or presence of IFN-β. GFP fluorescence indicates viral replication; fluorescence intensity and viral titers are shown below. D Cells transfected with the control vector or A104R were infected with VACV-GFP and treated with or without IFN-β. GFP fluorescence and quantitative analyses are shown. E Cells were transfected with the control vector or A104R and infected with HSV-GFP in the presence or absence of IFN-β. Fluorescence intensity and viral titers were determined. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment ( B – E ). Unpaired Student’s t -test was used for comparison between two independent groups ( B ). Significant group differences were analyzed one-way ANOVA followed by Tukey’s test ( C – E ). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. ns: not significant. Scale bar indicates 50 μm.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R inhibits IFN-β-induced JAK/STAT signaling. A Cells transfected with the vector control or A104R were treated with IFN-β for 0, 0.5, 1, 2, or 4 h. Phosphorylation of JAK1, TYK2, STAT1, and STAT2 was analyzed by immunoblotting. A104R expression was confirmed by detection of Flag-tagged A104R The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B The 3D4/21 cells were transfected with Flag-tagged A104R or the control vector and treated with IFN-β for 2 h. At the indicated timepoints, total RNA was extracted and the mRNA levels of the indicated genes were measured by RT-qPCR. C The 3D4/21 cells expressing the control vector or A104R were infected with ADV-GFP in the absence or presence of IFN-β. GFP fluorescence indicates viral replication; fluorescence intensity and viral titers are shown below. D Cells transfected with the control vector or A104R were infected with VACV-GFP and treated with or without IFN-β. GFP fluorescence and quantitative analyses are shown. E Cells were transfected with the control vector or A104R and infected with HSV-GFP in the presence or absence of IFN-β. Fluorescence intensity and viral titers were determined. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment ( B – E ). Unpaired Student’s t -test was used for comparison between two independent groups ( B ). Significant group differences were analyzed one-way ANOVA followed by Tukey’s test ( C – E ). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. ns: not significant. Scale bar indicates 50 μm.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Transfection, Plasmid Preparation, Control, Phospho-proteomics, Western Blot, Expressing, Quantitative RT-PCR, Infection, Fluorescence, Comparison

Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Journal: bioRxiv

Article Title: BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration—Implications for Combination Immunotherapy

doi: 10.64898/2026.11.04.764456

Figure Lengend Snippet: Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Article Snippet: Serum levels of IFN-γ (E-EL-M0048), TNF-α (E-EL-M3063), IL-10 (E-HSEL-M0004), CXCL9 (E-EL-M3077), and CXCL10 (E-EL-M0021) were measured using commercial ELISA kits (Elabscience, Wuhan, China) according to the manufacturer’s instructions.

Techniques:

Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Journal: bioRxiv

Article Title: BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration—Implications for Combination Immunotherapy

doi: 10.64898/2026.11.04.764456

Figure Lengend Snippet: Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Article Snippet: Serum levels of IFN-γ (E-EL-M0048), TNF-α (E-EL-M3063), IL-10 (E-HSEL-M0004), CXCL9 (E-EL-M3077), and CXCL10 (E-EL-M0021) were measured using commercial ELISA kits (Elabscience, Wuhan, China) according to the manufacturer’s instructions.

Techniques:

Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Journal: bioRxiv

Article Title: BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration—Implications for Combination Immunotherapy

doi: 10.64898/2026.11.04.764456

Figure Lengend Snippet: Two-group comparisons were performed using Welch’s t-test; multi-group comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. (a) IFN-γ. (b) TNF-α. (c) IL-10. (d) CXCL9. (e) CXCL10.

Article Snippet: Serum levels of IFN-γ (E-EL-M0048), TNF-α (E-EL-M3063), IL-10 (E-HSEL-M0004), CXCL9 (E-EL-M3077), and CXCL10 (E-EL-M0021) were measured using commercial ELISA kits (Elabscience, Wuhan, China) according to the manufacturer’s instructions.

Techniques:

(A) Schematics of NK cell activating receptors. B Gene (left) and protein (right) schematics of the chimeric receptors. C Membrane surface expression of chimeric receptors on NK92MI cell line determined by flow cytometry. D Mean fluorescence intensity (MFI) of CD69 expression on transduced NK92MI cells, determined by flow cytometry, after 24 hours coculture with CD19⁺ Nalm6 cells. ( E and F ) Cytokine productions of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours. IFN-γ ( E ) and TNF-α ( F ) were measured. G Degranulation marker CD107a of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. H Cytotoxicity of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1.Data are presented as mean with SD (n = 3; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: (A) Schematics of NK cell activating receptors. B Gene (left) and protein (right) schematics of the chimeric receptors. C Membrane surface expression of chimeric receptors on NK92MI cell line determined by flow cytometry. D Mean fluorescence intensity (MFI) of CD69 expression on transduced NK92MI cells, determined by flow cytometry, after 24 hours coculture with CD19⁺ Nalm6 cells. ( E and F ) Cytokine productions of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours. IFN-γ ( E ) and TNF-α ( F ) were measured. G Degranulation marker CD107a of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. H Cytotoxicity of chimeric receptors engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1.Data are presented as mean with SD (n = 3; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Membrane, Expressing, Flow Cytometry, Fluorescence, Marker, Two Tailed Test

A Gene (left) and protein (right) schematics of the chimeric NCR1 and KIR3DS1 receptors with CD8α transmembrane domain or transmembrane domain mutation. B Membrane surface expression of chimeric NCR1 receptors on NK92MI cell line determined by flow cytometry. ( C and D ) Normalized IFN-γ secretion of chimeric NCR1 receptors engineered NK92MI cells upon Nalm6 C and Raji ( D ) cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:5. E Membrane surface expression of chimeric KIR3DS1 receptors on NK92MI cell line determined by flow cytometry. ( F and G ) Normalized IFN-γ secretion of chimeric NCR1 receptors engineered NK92MI cells upon Nalm6 F and Raji ( G ) cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:5. Data are presented as mean with SD (n = 3; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: A Gene (left) and protein (right) schematics of the chimeric NCR1 and KIR3DS1 receptors with CD8α transmembrane domain or transmembrane domain mutation. B Membrane surface expression of chimeric NCR1 receptors on NK92MI cell line determined by flow cytometry. ( C and D ) Normalized IFN-γ secretion of chimeric NCR1 receptors engineered NK92MI cells upon Nalm6 C and Raji ( D ) cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:5. E Membrane surface expression of chimeric KIR3DS1 receptors on NK92MI cell line determined by flow cytometry. ( F and G ) Normalized IFN-γ secretion of chimeric NCR1 receptors engineered NK92MI cells upon Nalm6 F and Raji ( G ) cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:5. Data are presented as mean with SD (n = 3; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Mutagenesis, Membrane, Expressing, Flow Cytometry, Two Tailed Test

A Cross-species conservation analysis of NCR1 intracellular domain. B On-membrane phase separation between NCR1 intracellular domain mutations and Lck. Lck UD-SH3-SH2 was coated on supporting lipid bilayer (SLB), NCR1 cytoplasmic tail was added and incubated at room temperature for 30 min. C Lck clustering in images shown in ( B ) was quantified as described in Materials and Methods. ( D and E ), Cytokine productions of NCR1-based SPARC and its mutations engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ ( D ) and TNF-α ( E ) were measured. F Degranulation marker CD107a of NCR1-based SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. G Cytotoxicity of NCR1-based SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. H IFN-γ secretion of NCR1-based SPARC-NK92MI cells upon Nalm6 cells blocked by soluble FMC63 stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: A Cross-species conservation analysis of NCR1 intracellular domain. B On-membrane phase separation between NCR1 intracellular domain mutations and Lck. Lck UD-SH3-SH2 was coated on supporting lipid bilayer (SLB), NCR1 cytoplasmic tail was added and incubated at room temperature for 30 min. C Lck clustering in images shown in ( B ) was quantified as described in Materials and Methods. ( D and E ), Cytokine productions of NCR1-based SPARC and its mutations engineered NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ ( D ) and TNF-α ( E ) were measured. F Degranulation marker CD107a of NCR1-based SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. G Cytotoxicity of NCR1-based SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. H IFN-γ secretion of NCR1-based SPARC-NK92MI cells upon Nalm6 cells blocked by soluble FMC63 stimulation for 24 hours at an effector:target (E:T) ratio of 1:1. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Analysis, Membrane, Incubation, Marker, Two Tailed Test

A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of SPARC-Jurkat cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: A Gene schematics of the chimeric NCR1 receptors with CD8α stalk and TCRα mutation transmembrane domain. B Surface expression of SPARCs in ( A ) on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Surface expression of SPARC-Jurkat cells by flow cytometry. E IL-2 secretion of SPARC-Jurkat cells upon Raji cells stimulation for 24 hours. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Mutagenesis, Expressing, Flow Cytometry, Two Tailed Test

A Gene (left) and protein (right) schematics of the SPARC with 4-1BB co-stimulatory domain and BBz CAR. B Surface expression of SPARC and CAR on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Schematic representation of the in vitro experiment for primary T cells and NK92MI cells combined therapy. E Surface expression of SPARCs and CAR on primary T cells by flow cytometry. F IFN-γ secretion in the supernatants from co-culture of SPARC- and CAR-NK92MI cells and T cells upon Raji cells stimulation for 24 hours at the indicated cell numbers. Raji cells is 20000 per well. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: A Gene (left) and protein (right) schematics of the SPARC with 4-1BB co-stimulatory domain and BBz CAR. B Surface expression of SPARC and CAR on NK92MI cells by flow cytometry. C Cytokine productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours at the indicated effector:target (E:T) ratios. IFN-γ (left) and TNF-α (right) were measured. D Schematic representation of the in vitro experiment for primary T cells and NK92MI cells combined therapy. E Surface expression of SPARCs and CAR on primary T cells by flow cytometry. F IFN-γ secretion in the supernatants from co-culture of SPARC- and CAR-NK92MI cells and T cells upon Raji cells stimulation for 24 hours at the indicated cell numbers. Raji cells is 20000 per well. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Expressing, Flow Cytometry, In Vitro, Co-culture Assay, Two Tailed Test

A Gene (left) and protein (right) schematics of the SPARC with NCR1 and 4-1BB dual ICD, NCR1 R-A -NCR1BBz and CD8-NCR1BBz CAR. B IFN-γ productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours. C IL-2 productions of SPARC-T cells upon Raji cells stimulation for 24 hours. D IFN-γ secretion in the supernatants from co-culture of SPARC- and CAR-NK92MI cells and T cells upon Raji cells stimulation for 24 hours at the indicated cell numbers. Raji cells is 20000 per well. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Journal: bioRxiv

Article Title: A biomimetic SPARC platform coupling adaptor recruitment and BRS-Lck condensation for enhanced NK/T cell combination therapy

doi: 10.64898/2026.11.02.763574

Figure Lengend Snippet: A Gene (left) and protein (right) schematics of the SPARC with NCR1 and 4-1BB dual ICD, NCR1 R-A -NCR1BBz and CD8-NCR1BBz CAR. B IFN-γ productions of SPARC-NK92MI cells upon Nalm6 cells stimulation for 24 hours. C IL-2 productions of SPARC-T cells upon Raji cells stimulation for 24 hours. D IFN-γ secretion in the supernatants from co-culture of SPARC- and CAR-NK92MI cells and T cells upon Raji cells stimulation for 24 hours at the indicated cell numbers. Raji cells is 20000 per well. Data are presented as mean with SD (n = 3; ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001; ns, nonsignificant; unpaired two-tailed Student’s t-test for comparisons).

Article Snippet: The cytokine concentrations were measured using following ELISA kits according to the manufacturer’s protocol: human IL-2 (Boster, EK0397), human IFN-γ (Boster, EK0373) and human TNF-α (Boster, EK0525).

Techniques: Co-culture Assay, Two Tailed Test

(A) Validation of FLAG-Dicer immunoprecipitation (used for proteomics) in HEK293-L cells treated with siControl, siADAR1, or siADAR1 + ruxolitinib (n=3). Input and IP fractions analysed by immunoblot. EV, empty vector; siA, siADAR1; Rux, ruxolitinib. (B) Principal component analysis of proteomics samples from (A); biological replicates indicated by matching symbols. (C-D) Volcano plots showing changes in Dicer interactome 72h after siADAR1 treatment (n=3). Enriched Dicer interactors in siADAR1 treated samples are highlighted in purple. (C) Enriched Dicer interactors after siADAR1 treatment, versus siControl. (D) Enriched Dicer interactors in siADAR1 + ruxolitinib treatment, versus siControl. (E) Transcript levels of enriched Dicer interactors after siADAR1 treatment in (C) (n=3). Transcript levels shown as the fold change of the counts per million (CPM) after siADAR1 treatment from transcriptomics shown in of HEK293-L cells, 72h post-siRNA transfection. (F) GO-enrichment analysis of Dicer interactors 72h post-siRNA transfection. Color-coded by GO-term similarity; ribosome-related GO-terms are labelled green and translation-related GO-terms are labelled blue. (G) Volcano plot of Dicer interactome after 72h in siControl-treated HEK293-L cells (n=3). Interactors overlapping with the GO term Regulation of type I IFN response are named and highlighted red, or blue for those chosen for further study. Curved line in volcano plots indicates the significance boundary based on a hyperbolic threshold combining fold change and p-value criteria.

Journal: bioRxiv

Article Title: A non-canonical function of Dicer fuels inflammation driven by self-dsRNAs

doi: 10.64898/2026.10.29.761885

Figure Lengend Snippet: (A) Validation of FLAG-Dicer immunoprecipitation (used for proteomics) in HEK293-L cells treated with siControl, siADAR1, or siADAR1 + ruxolitinib (n=3). Input and IP fractions analysed by immunoblot. EV, empty vector; siA, siADAR1; Rux, ruxolitinib. (B) Principal component analysis of proteomics samples from (A); biological replicates indicated by matching symbols. (C-D) Volcano plots showing changes in Dicer interactome 72h after siADAR1 treatment (n=3). Enriched Dicer interactors in siADAR1 treated samples are highlighted in purple. (C) Enriched Dicer interactors after siADAR1 treatment, versus siControl. (D) Enriched Dicer interactors in siADAR1 + ruxolitinib treatment, versus siControl. (E) Transcript levels of enriched Dicer interactors after siADAR1 treatment in (C) (n=3). Transcript levels shown as the fold change of the counts per million (CPM) after siADAR1 treatment from transcriptomics shown in of HEK293-L cells, 72h post-siRNA transfection. (F) GO-enrichment analysis of Dicer interactors 72h post-siRNA transfection. Color-coded by GO-term similarity; ribosome-related GO-terms are labelled green and translation-related GO-terms are labelled blue. (G) Volcano plot of Dicer interactome after 72h in siControl-treated HEK293-L cells (n=3). Interactors overlapping with the GO term Regulation of type I IFN response are named and highlighted red, or blue for those chosen for further study. Curved line in volcano plots indicates the significance boundary based on a hyperbolic threshold combining fold change and p-value criteria.

Article Snippet: Universal Type I IFN (IFN-I, 11200, PBL Assay Science) was used at specified concentrations.

Techniques: Biomarker Discovery, Immunoprecipitation, Proteomic Assay, Western Blot, Plasmid Preparation, Analysis, Transcriptomics, Transfection, RNA Sequencing